BMY vs EXPD · P/E 17, rev $24.46B vs P/E 26, rev $6.29B
Bristol-Myers Squibb Company (BMY) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the BMY and EXPD stock pages for the full models.
Not investment advice.